Ointment for plaque psoriasis
Part of Skin clinical trials.
This trial tests an ointment (RSS0393) for plaque psoriasis. It aims to see if the ointment reduces the size and severity of psoriasis patches and is safe to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had plaque psoriasis for at least 6 months.
- Your psoriasis covers between 2% and 20% of your body (about the size of 2 to 20 palms).
- You do not have other types of psoriasis (like guttate or pustular) or other skin conditions that could interfere.
- You do not have a history of cancer in the last 5 years (except certain cured skin cancers).
- You are not currently pregnant or breastfeeding, and you use effective contraception if you are of childbearing potential.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an ointment called RSS0393 to see if it safely reduces the redness, thickness, and scaling of plaque psoriasis. It may help if you have mild-to-moderate psoriasis that is not well controlled with current treatments.
This study tests whether a new ointment (called RSS0393) is safe and works well for young people with plaque psoriasis. It may help reduce the thick, scaly patches of skin caused by this condition.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
This study tests an investigational medicine (HS-20118) for people with moderate-to-severe plaque psoriasis. The goal is to see if the drug can safely and effectively reduce psoriasis symptoms and improve quality of life.
Hear when a new Psoriatic Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.